FDA Clears IotaMotion’s Robotic CI Insertion System for Expanded Pediatric Use
The IotaSoft robotic-assisted cochlear implant insertion system is now cleared for use in children aged four and older.
The IotaSoft robotic-assisted cochlear implant insertion system is now cleared for use in children aged four and older.
Hearing care professionals can help prepare families to use the natural, supportive setting of holiday gatherings to recognize early signs of hearing loss and encourage empathetic conversations that can lead to improved hearing health and quality of life.
The start of the school year often inspires a “Fall refresh,” encouraging professionals to embrace new learning, reconsider established methods, and explore fresh approaches.
A major longitudinal study of more than 3,300 teens finds that by age 18, one in eight adolescents shows signs of probable noise-induced hearing damage and over 6% have sensorineural hearing loss.
Regeneron’s DB-OTO gene therapy for genetic hearing loss is one of nine drugs to receive expedited review under FDA's new CNPV program.
Neurotone AI has launched Tinnitus Pro, a personalized digital tinnitus therapy platform that blends sound therapy, CBT-based tools, and clinician-connected monitoring.
Sottovoce has developed a real-time performance management platform to help orchestras monitor and reduce musicians’ noise exposure, promoting safer, more sustainable hearing health practices across the performing arts industry.
A 14-year-old girl’s vestibular evaluation reveals overlapping signs of vestibular migraine and postural orthostatic tachycardia syndrome (POTS), complicating the diagnosis.
Peter Aksel Villadsen discusses how the Listen To This initiative is driving awareness of hearing health as essential to cognitive function, healthy aging, and overall wellbeing.